Free Trial

Flora Growth (FLGC) Competitors

$1.19
+0.06 (+5.31%)
(As of 06/6/2024 ET)

FLGC vs. OCC, CELU, RPHM, THTX, MURA, AEON, CARM, IMMX, ANEB, and RMTI

Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Optical Cable (OCC), Celularity (CELU), Reneo Pharmaceuticals (RPHM), Theratechnologies (THTX), Mural Oncology (MURA), AEON Biopharma (AEON), Carisma Therapeutics (CARM), Immix Biopharma (IMMX), Anebulo Pharmaceuticals (ANEB), and Rockwell Medical (RMTI).

Flora Growth vs.

Optical Cable (NASDAQ:OCC) and Flora Growth (NASDAQ:FLGC) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and community ranking.

In the previous week, Flora Growth had 1 more articles in the media than Optical Cable. MarketBeat recorded 1 mentions for Flora Growth and 0 mentions for Optical Cable. Optical Cable's average media sentiment score of 0.35 beat Flora Growth's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media.

Company Overall Sentiment
Optical Cable Neutral
Flora Growth Neutral

13.6% of Optical Cable shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 23.0% of Optical Cable shares are owned by insiders. Comparatively, 17.6% of Flora Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Optical Cable has a net margin of -0.24% compared to Optical Cable's net margin of -75.95%. Flora Growth's return on equity of -6.09% beat Optical Cable's return on equity.

Company Net Margins Return on Equity Return on Assets
Optical Cable-0.24% -6.09% -3.45%
Flora Growth -75.95%-144.44%-43.20%

Optical Cable has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500.

Flora Growth has a consensus target price of $6.00, suggesting a potential upside of 404.20%. Given Optical Cable's higher probable upside, analysts plainly believe Flora Growth is more favorable than Optical Cable.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Optical Cable
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Flora Growth
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Optical Cable received 90 more outperform votes than Flora Growth when rated by MarketBeat users. Likewise, 64.60% of users gave Optical Cable an outperform vote while only 60.87% of users gave Flora Growth an outperform vote.

CompanyUnderperformOutperform
Optical CableOutperform Votes
104
64.60%
Underperform Votes
57
35.40%
Flora GrowthOutperform Votes
14
60.87%
Underperform Votes
9
39.13%

Optical Cable has higher earnings, but lower revenue than Flora Growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Optical Cable$68.74M0.31$2.07M-$0.03-91.67
Flora Growth$76.07M0.20-$57.04MN/AN/A

Summary

Optical Cable beats Flora Growth on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGC vs. The Competition

MetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$15.26M$7.01B$5.21B$8.18B
Dividend YieldN/A2.65%2.80%4.02%
P/E RatioN/A21.59178.9018.46
Price / Sales0.20238.702,383.4071.98
Price / CashN/A32.6134.6431.30
Price / Book1.535.774.984.39
Net Income-$57.04M$147.15M$109.94M$215.75M
7 Day Performance-4.03%0.40%0.49%0.05%
1 Month Performance-24.68%0.13%0.62%0.13%
1 Year Performance-75.61%-4.85%1.88%4.32%

Flora Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCC
Optical Cable
0 of 5 stars
$2.82
+0.7%
N/A-31.6%$21.99M$72.17M-93.97327Upcoming Earnings
CELU
Celularity
0 of 5 stars
$3.11
+4.4%
N/A-50.1%$57.75M$17.98M0.00225Upcoming Earnings
RPHM
Reneo Pharmaceuticals
2.2452 of 5 stars
$1.66
-3.5%
$11.01
+563.4%
-81.1%$57.48MN/A-0.768Positive News
THTX
Theratechnologies
0 of 5 stars
$1.25
flat
N/A-67.2%$57.47M$81.76M-2.05103Positive News
MURA
Mural Oncology
2.2474 of 5 stars
$3.36
+0.3%
$13.00
+286.9%
N/A$56.69MN/A0.00119Positive News
AEON
AEON Biopharma
1.0133 of 5 stars
$1.58
+9.7%
$6.00
+279.7%
N/A$56.34MN/A0.0010
CARM
Carisma Therapeutics
2.256 of 5 stars
$1.33
+1.5%
$9.00
+576.7%
-84.7%$55.25M$15.07M-0.67107Positive News
IMMX
Immix Biopharma
3.1126 of 5 stars
$2.11
+1.0%
$14.00
+563.5%
+0.5%$55.21MN/A-2.2714Positive News
ANEB
Anebulo Pharmaceuticals
2.2253 of 5 stars
$2.05
-2.4%
$6.67
+225.2%
-20.1%$54.46MN/A-5.542Gap Up
RMTI
Rockwell Medical
3.9044 of 5 stars
$1.76
-1.1%
$7.00
+298.9%
-55.7%$53.66M$83.61M-4.87237

Related Companies and Tools

This page (NASDAQ:FLGC) was last updated on 6/7/2024 by MarketBeat.com Staff

From Our Partners